Virology Journal (Aug 2021)
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021
- Alessia Lai,
- Annalisa Bergna,
- Stefano Menzo,
- Gianguglielmo Zehender,
- Sara Caucci,
- Valeria Ghisetti,
- Francesca Rizzo,
- Fabrizio Maggi,
- Francesco Cerutti,
- Giorgio Giurato,
- Alessandro Weisz,
- Chiara Turchi,
- Bianca Bruzzone,
- Francesca Ceccherini Silberstein,
- Nicola Clementi,
- Annapaola Callegaro,
- Fabio Sagradi,
- Daniela Francisci,
- Emmanuele Venanzi Rullo,
- Ilaria Vicenti,
- Massimo Clementi,
- Massimo Galli,
- collaborative group SCIRE SARS-CoV-2 Italian Research Enterprise
Affiliations
- Alessia Lai
- Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan
- Annalisa Bergna
- Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan
- Stefano Menzo
- Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche
- Gianguglielmo Zehender
- Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan
- Sara Caucci
- Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche
- Valeria Ghisetti
- Microbiology and Molecular Biology Laboratory, “Amedeo di Savoia” Hospital
- Francesca Rizzo
- Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ and Laboratory of Molecular Medicine and Genomics, University of Salerno
- Fabrizio Maggi
- Laboratory of Microbiology, ASST Sette Laghi
- Francesco Cerutti
- Microbiology and Molecular Biology Laboratory, “Amedeo di Savoia” Hospital
- Giorgio Giurato
- Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ and Laboratory of Molecular Medicine and Genomics, University of Salerno
- Alessandro Weisz
- Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ and Laboratory of Molecular Medicine and Genomics, University of Salerno
- Chiara Turchi
- Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche
- Bianca Bruzzone
- Hygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences
- Francesca Ceccherini Silberstein
- Department of Experimental Medicine, University of Rome “Tor Vergata”
- Nicola Clementi
- Laboratory of Microbiology and Virology, Università “Vita-Salute” San Raffaele
- Annapaola Callegaro
- Biobank Unit and Microbiology and Virology Laboratory, ASST Papa Giovanni XXIII
- Fabio Sagradi
- Haemostasis and Thrombosis Center, A.S.S.T. Cremona
- Daniela Francisci
- Department of Medicine and Surgery, Clinic of Infectious Diseases, “Santa Maria della Misericordia” Hospital, Università degli Studi di Perugia
- Emmanuele Venanzi Rullo
- Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Messina
- Ilaria Vicenti
- Department of Medical Biotechnologies, University of Siena
- Massimo Clementi
- Laboratory of Microbiology and Virology, Università “Vita-Salute” San Raffaele
- Massimo Galli
- Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan
- collaborative group SCIRE SARS-CoV-2 Italian Research Enterprise
- DOI
- https://doi.org/10.1186/s12985-021-01638-5
- Journal volume & issue
-
Vol. 18,
no. 1
pp. 1 – 5
Abstract
Abstract A growing number of emerging SARS-CoV-2 variants is being identified worldwide, potentially impacting the effectiveness of current vaccines. We report the data obtained in several Italian regions involved in the SARS-CoV-2 variant monitoring from the beginning of the epidemic and spanning the period from October 2020 to March 2021.
Keywords
